Paychex reports $1.61B Q4 revenue, boosts 2027 outlook
Paychex (NASDAQ:PAYX) reported fourth-quarter fiscal 2026 revenue of $1.61 billion, reflecting a 12% increase compared with the same period last year.
Every story in this section, newest first — page 144 of 373.
Paychex (NASDAQ:PAYX) reported fourth-quarter fiscal 2026 revenue of $1.61 billion, reflecting a 12% increase compared with the same period last year.
InMode (NASDAQ:INMD) said its board received an unsolicited proposal on June 17, 2026 from M.N. Business Strategy to acquire all outstanding ordinary shares it does not already own for $16.20 per share in cash.
Kaspi.kz (NASDAQ:KSPI) received regulatory approval from Türkiye’s Banking Regulation and Supervision Agency (BDDK) to acquire Rabobank A.Ş., a fully licensed Turkish bank.
EXL Service Holdings (NASDAQ:EXLS) signed a definitive agreement to acquire iMerit, a company specializing in AI model training, evaluation, and reinforcement learning services, in a transaction valued at up to $310 million.
Qualcomm Incorporated (NASDAQ:QCOM) has reached an agreement to acquire Modular, strengthening Qualcomm Technologies’ software foundation for generative and agentic AI across data center and edge environments.
Gaxos (NASDAQ:GXAI) completed the sale of its gaming assets, including mobile games and Gaxos Gaming Labs, to privately held Game Foundry AI in an all-stock transaction valued at approximately $1.76 million.
PodcastOne (NASDAQ:PODC) reported record fiscal 2026 revenue of $61.7 million, an increase of 18% from the prior year.
Viking Therapeutics (NASDAQ:VKTX) has started a Phase 1 single ascending dose study of VK3019 in healthy adults with a body mass index of 30 or higher.
Cognition Therapeutics (NASDAQ:CGTX) reported FDA alignment on key elements of a pivotal Phase 3 trial of zervimesine (CT1812) for the treatment of psychosis in dementia with Lewy bodies (DLB).
ADC Therapeutics (NYSE:ADCT) announced a strategic reorganization aimed at prioritizing its ZYNLONTA franchise and advancing key clinical programs including LOTIS-5 and LOTIS-7.
REGENXBIO (NASDAQ:RGNX) said it has completed dosing in the confirmatory study of RGX-202, an investigational gene therapy for Duchenne muscular dystrophy, marking completion of its registrational development program.
Teledyne Technologies Incorporated (NYSE:TDY) announced that its Teledyne FLIR Defense unit has received a $28.8 million contract from U.S. Customs and Border Protection to support the Enhanced Mobile Surveillance Capability–Lite program.
CalciMedica (NASDAQ:CALC) reported that the U.S. Food and Drug Administration reviewed a protocol amendment and interim safety data from its Phase 2 KOURAGE trial and provided no comments, allowing dosing to continue.
Bowman (NASDAQ:BWMN) secured $11.2 million in new USDA aerial acquisition awards under the PINE Blanket Purchase Agreement.
Gilat Satellite Networks (NASDAQ:GILT) received a multi-million dollar order from a European Ministry of Defense for custom satellite communications terminals, with deliveries expected over the next 12 months.
Crown Crafts (NASDAQ:CRWS) reported fourth quarter fiscal 2026 net sales of $22.4 million compared with $23.2 million in the prior-year quarter.
Merck (NYSE:MRK) announced that the European Commission approved KEYTRUDA (pembrolizumab), in combination with Padcev (enfortumab vedotin-ejfv), as neoadjuvant treatment followed by adjuvant treatment after radical cystectomy for adults with resectable muscle-invasive bladder cancer who are ineligible for cisplatin-containing chemotherapy.
Helus Pharma (NASDAQ:HELP) reported that its APPROACH Phase 3 trial of HLP003 for adjunctive treatment of major depressive disorder has surpassed 86% enrollment and is progressing as planned.
Absci Corp (NASDAQ:ABSI) reported positive interim Phase 1 data from the HEADLINE trial evaluating ABS-201, an investigational anti-PRLR antibody in development.
Rockstar Games, a publishing label of Take-Two Interactive Software (NASDAQ:TTWO), will begin pre-orders for Grand Theft Auto VI on June 25, 2026 at midnight local time.
MoneyHero (NASDAQ:MNY) reported first-quarter 2026 revenue of $16.5 million, representing a 15% increase compared with the same period last year.
Advanced Sterilization Products (ASP), part of Fortive (NYSE:FTV), has acquired a majority share of UV Smart, a leader in High Level Disinfection technology in Europe.
Agility Robotics and Churchill Capital Corp XI (NASDAQ:CCXI) have entered into a definitive business combination agreement.
Powerlaw (NASDAQ:PWRL) is highlighting its exposure to the prediction market platform Kalshi following reports that the company has surpassed $2 billion in annualized revenue.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy